Live Attenuated Bacillus Anthracis Vaccine [EPC] - N0000183903

Pharmacologic Class Information

Pharmacologic Code N0000183903
Pharmacologic Name Live Attenuated Bacillus Anthracis Vaccine
Pharmacologic Uses
  • live attenuated Bacillus anthracis vaccine
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Live Attenuated Bacillus Anthracis Vaccine

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Live Attenuated Bacillus Anthracis Vaccine [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
64678-211Biothrax Non-Proprietary Name: Bacillus AnthracisInjection, SuspensionIntramuscular; SubcutaneousEmergent Biodefense Operations Lansing, LlcACTIVE
71665-001Cyfendus Non-Proprietary Name: Anthrax Vaccine Adsorbed, AdjuvantedInjection, SuspensionIntramuscularEmergent Product Development Gaithersburg Inc.ACTIVE